Laboratorio Clinica Principal San Fernando Laboratorios/Clinicos is categorized under Medical Labs in , and active since 2010.
Laboratorio Clinica Principal San Fernando Laboratorios/Clinicos was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 1 Res Magnolia Gardens Adm, , 00956 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Laboratorio Clinica Principal San Fernando Laboratorios/Clinicos |
Address: | 1 Res Magnolia Gardens Adm, , 00956 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Labs |
SIC Code: | 8071 |
NAICS Code: | 621511 |
Share This Business: |
Laboratorio Clinica Principal San Fernando Laboratorios/Clinicos was started in 2010 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact for inquiries that concern Laboratorio Clinica Principal San Fernando Laboratorios/Clinicos by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Laboratorio Clinica Principal San Fernando Laboratorios/Clinicos can be found at the coordinates as well as the street address 1 Res Magnolia Gardens Adm in , 00956.
For its online presence, you may visit Laboratorio Clinica Principal San Fernando Laboratorios/Clinicos’s website at and engage with its social media outlets through on Twitter and on Facebook.